US FDA Consults On Publicizing Emerging, Unconfirmed Medical Device Signals
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is seeking feedback on its proposal to alert patients, healthcare providers and the general public about post-market device risks before performing a full analysis or developing specific recommendations1,2.